Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: NeisVac-C
Active Ingredients: Neisseria meningitidis, Group C 10µg/dose
Tetanus toxoid 10µg/dose – 20µg/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Dated this 17th day of March 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).